A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine - MI-MA205

Study identifier:MI-MA205

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a New 6:2 Influenza Virus Reassortant in Healthy Adults

Medical condition

Healthy

Phase

Phase 4

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

300

Study type

Interventional

Age

18 Years - 49 Years

Date

Study Start Date: 01 May 2009
Primary Completion Date: 01 May 2009
Study Completion Date: 01 Dec 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Prevention

Verification:

Verified 01 Jul 2011 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria